The no-observed-adverse-effect-level in drug safety evaluations: Use, issues, and definition(s) 论文

2005Regulatory Toxicology and Pharmacology引用 238
DOI
Animal testing and alternativesComputational Drug Discovery MethodsStatistical Methods in Clinical Trials
Computational Drug Discovery MethodsStatistical Methods in Clinical TrialsAnimal testing and alternatives
相关技术:Statistical Methods in Clinical TrialsComputational Drug Discovery Methods
关系图谱

The no-observed-adverse-effect-level in drug safety evaluations: Use, issues, and definition(s) · 作者

J

Jeffery A. Engelhardt

M

Michael A. Dorato